About this trial
The aim of this study is to compare the clinical efficacy and safety of ultrasound-guided pulsed radiofrequency and hyaluronidase hydrodissection in the treatment of carpal tunnel syndrome. This research seeks to evaluate both techniques in terms of pain relief, functional improvement, nerve conduction parameters, and potential complications, in order to identify the more effective minimally invasive approach for managing carpal tunnel syndrome.
Eligibility criteria
Qualifiers
Adults aged 20-80 years
Clinical diagnosis of CTS with symptoms for at least 3 months
Electrophysiological evidence of mild to moderate CTS
No previous intervention for CTS in the affected hand
Disqualifiers
Previous wrist surgery or trauma
Medical history of polyneuropathy, thoracic outlet syndrome, or brachial plexopathy
Coagulopathy or local infection at injection site
Pregnancy or breastfeeding
Trial design
Treatments tested in this trial
- Pulsed Radiofrequency
- Hyaluronidase Hydrodissection